CME-Pod

This educational session, which was recorded during our Grand Rounds series conducted in 2025-2026 with Dr. Martin Dietrich, affords learners a timely and succinct overview of the rapidly evolving ES-SCLC treatment landscape, with a keen focus on the best practice mitigation and management of chemotherapy-induced myelosuppression (CIM), a major challenge in ES-SCLC care. More specifically, Dr. Die...

Originally presented as a satellite symposium at the 2025 HFSA Annual Scientific Meeting in Minneapolis, this educational activity is targeted to cardiologists, neurologists, heart failure specialists, and the interprofessional team of nurse practitioners and cardiac nurses that help manage patients with transthyretin-mediated amyloidosis (ATTR). Designed as both a data intensive and a case-based...

To take the post-test and claim your CE credit for this session, please visit: https://online.epocrates.com/contextuallink/cme/activity/OQUMHW This educational initiative is targeted to the community-based multidisciplinary and interprofessional HHT treatment team of primary care physicians, internists, hematologists, oncologists, gastroenterologists, otorhinolaryngologists, allergists, and nurses...

In this episode of CME-Pod, leading clinical experts - Drs. Truman Milling, Jr, Deborah Siegal, and Geoffrey Barnes - will provide learners with a circumscription of the clinical benefits and risks associated with DOAC usage, inclusive of patient-specific, disease-specific, and drug-specific risk factors, and will examine the unique pharmacologic mechanisms of established and emerging specific rev...